From the publishers of JADPRO

Bone Protection Resource Center

Advertisement

Lung Cancer

Randomized phase II study of zoledronate dosing every four versus eight weeks in patients with bone metastasis from lung cancer (Hanshin Cancer Group0312)

Current Osteoporosis Reports

Checkpoint inhibitors in bone metastatic disease in solid tumors

Journal of Bone Oncology

Therapeutic approaches in patients with bone metastasis due to endometrial carcinoma – A systematic review

Oncology Nursing News

Bisphosphonates may reduce fracture risk in patients with metastatic hormone-sensitive prostate cancer

Scientific Reports

Long-term use of denosumab and its association with skeletal-related events and osteonecrosis of the jaw

Journal of Bone Oncology

How has the field of metastatic breast cancer in bones evolved over the past 22 years?

Cancer Epidemiology

Low baseline vitamin D levels increase the risk of bone metastases among females with breast cancer − Hospital based cohort study

BMJ Open

Assessment of bone-targeting agents use in patients with bone metastasis from breast, lung or prostate cancer using structured and unstructured electronic health records from a regional UK-based hospital

Oncology Letters

Prognostic assessment of patients who receive radiotherapy for bone metastases from breast cancer

The Oncologist

Bone metastases detection in patients with breast cancer: Does bone scintigraphy add information to PET/CT?

Cancers

Initiation of antiresorptive drug treatment during endocrine therapy for breast cancer—A retrospective cohort study of 161,492 patients in Germany

Journal of Bone and Mineral Metabolism

Differences between zoledronic acid and denosumab for breast cancer treatment

Frontiers in Oncology

Management of pain in patients with bone metastases

Radiation Oncology

Early death after palliative radiation treatment: 30-, 35- and 40-day mortality data and statistically robust predictors

Journal of Bone Oncology

Management of bone metastasis with zoledronic acid: A systematic review and Bayesian network meta-analysis

European Journal of Cancer

Efficacy and safety of nivolumab in bone metastases from renal cell carcinoma: Results of the GETUG-AFU26-NIVOREN multicentre phase II study

2023 ASCO Genitourinary Cancers Symposium Abstract

Circulating tumor DNA and homologous recombination deficiency in bone-predominant mCRPC prior to radium-223 therapy

2023 ASCO Genitourinary Cancers Symposium Abstract

Patient characteristics and safety of radium-223 dichloride in Taiwan: Analysis of real-world clinical practice

Urologic Oncology: Seminars and Original Investigations

A prospective, multicenter head-to-head comparative study in patients with primary high-risk prostate cancer investigating the bone lesion detection of conventional imaging and 18F-PSMA-PET/CT

The Lancet

Intra-individual comparison of 18F-sodium fluoride PET–CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial

The ASCO Post

Randomized phase II trial shows benefits of prophylactic radiation therapy for asymptomatic bone metastases

Scientific Reports

TOR1B: a predictor of bone metastasis in breast cancer patients

Journal of Pain Research

The burden of metastatic cancer–induced bone pain: A narrative review

The ASCO Post

Prophylactic radiation for asymptomatic bone metastases may reduce pain and extend survival

Scientific Reports

Head-to-head comparison of 99mTc-PSMA and 99mTc-MDP SPECT/CT in diagnosing prostate cancer bone metastasis: a prospective, comparative imaging trial

eJHaem

The importance of retaining physical functions to prevent skeletal-related events in multiple myeloma patients with bone disease

Supportive Care in Cancer

Medication adherence with denosumab in patients with bone metastases from solid tumors treated in routine clinical settings: a retrospective study

AACR 2022 Abstract

Racial/ethnic disparities in treatment with bone-modifying agents among newly diagnosed multiple myeloma patients

Cancers

Daratumumab improves bone turnover in relapsed/refractory multiple myeloma; phase 2 study “REBUILD”

Journal of Bone Oncology

Fracture risk in breast cancer: Does obesity have an effect? A scoping review

Seminars in Oncology Nursing

Bone health in metastatic cancer

Seminars in Oncology Nursing

Associations among physical activity, skeletal related events, and patient reported outcomes in patients with bone metastases

Journal of Bone Oncology

Impact of adjuvant imatinib on bone and muscle density in patients with resected gastrointestinal stromal tumors

Journal of Bone Oncology

State-of-the-art of minimally invasive treatments of bone metastases

Journal of Thoracic Disease

Bone metastases in non-small cell lung cancer: a narrative review

Journal of Bone Oncology

Risk factors associated with skeletal-related events following discontinuation of denosumab treatment among patients with bone metastases from solid tumors: a real-world machine learning approach

BioDrugs

Comparative treatment persistence with bone-targeting agents among Asian patients with bone metastases from solid tumors: a multinational retrospective cohort study

Future Oncology

Long-term safety and efficacy of bisphosphonate therapy in advanced lung cancer with bone metastasis

Nuclear Medicine Communications

Bone scan with technetium 99m-methyl diphosphonate, the missing link in the initial staging of muscle-invasive bladder carcinoma

Supportive Care in Cancer

3-T magnetic resonance–guided high-intensity focused ultrasound (3 T-MR-HIFU) for the treatment of pain from bone metastases of solid tumors

Practical Radiation Oncology

Longitudinal changes in bone mineral measurements inside and outside radiation fields used for cervical cancer treatment

ASCO Annual Meeting 2022

Bone mineral density (BMD) deficits in adult survivors of childhood cancer: Attributable risks and long-term consequences

ASCO Annual Meeting 2022

Long-term outcomes of adjuvant denosumab in breast cancer: Fracture reduction and survival results from 3,425 patients in the randomised, double-blind, placebo-controlled ABCSG-18 trial

Journal of Bone Oncology

Real-world patient-reported outcomes of breast cancer or prostate cancer patients receiving antiresorptive therapy for bone metastases: final results of the PROBone Registry Study

Healio: Navigating Survivorship

Physicians must ‘take responsibility’ for bone health of cancer survivors

International Journal of Oral & Maxillofacial Surgery

Osteonecrosis of the jaw among cancer patients in Denmark: risk and prognosis

Current Oncology

Bone targeting agents in patients with prostate cancer: general toxicities and osteonecrosis of the jaw

Journal of Nuclear Medicine

mCRPC patients receiving 225Ac-PSMA-617 therapy in post androgen deprivation therapy setting: response to treatment and survival analysis

JAMA Open Network

Association of bone mineral density testing with risk of major osteoporotic fractures among older men receiving androgen deprivation therapy to treat localized or regional prostate cancer

Journal of Clinical Oncology

Impact of the oncology care model on use of supportive care medications during cancer treatment

Healthcare

Association between overall survival and activities of daily living in patients with spinal bone metastases

Cancers

Advancing treatment of bone metastases through novel translational approaches targeting the bone microenvironment

2022 ASCO Genitourinary Cancers Symposium (Abstract)

Bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone plus prednisone in the PEACE-1 phase 3 trial.

2022 ASCO Genitourinary Cancers Symposium (Abstract)

Improvements in symptoms related to bone metastasis in recipients of Lutetium-177 PSMA-617 for prostate cancer

Irish Journal of Medical Science

The efficacy of a comprehensive bone health program in maintaining bone mineral density in postmenopausal women with early-stage breast cancer treated with endocrine therapy: real-world data

Supportive Care in Cancer

Symptomatic skeletal-related events in patients receiving longer term bone-modifying agents for bone metastases from breast and castration resistant prostate cancers

Oncology Nurse Advisor

Strategies for managing chronic pain in patients with bone-metastatic CRPC

Frontiers in Bioscience

Bone health and therapeutic agents in advanced prostate cancer

Journal of Clinical Oncology

Use of adjuvant bisphosphonates and other bone-modifying agents in breast cancer: ASCO-OH (CCO) guideline update

Metabolism

Effect of antiresorptive therapy on aromatase inhibitor induced bone loss in postmenopausal women with early-stage breast cancer: A systematic review and meta-analysis of randomized controlled trials

Annals of Pharmacotherapy

Impact of Extended-Interval Versus Standard Dosing of Zoledronic Acid on Skeletal Events in Non–Small-Cell Lung Cancer and Small-Cell Lung Cancer Patients With Bone Metastases

JAMA Open Network

Description of Major Osteoporotic Fractures in Women With Invasive Breast Cancer Who Received Endocrine Therapy

Journal of Bone Oncology

Bone Metastases From Urothelial Carcinoma. The Dark Side of the Moon

JAMA Open Network

Evaluation of Frequency of Administration of Intravenous Bisphosphonate and Recurrent Skeletal-Related Events in Patients With Multiple Myeloma

Journal of the National Comprehensive Cancer Network

Bone Metastases, Skeletal-Related Events, and Survival in Patients With Metastatic Non–Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors

JAMA Network Open

Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line Therapy

Current Osteoporosis Reports

Updates in Management of Bone Metastatic Disease in Primary Solid Tumors with Systemic Therapies

Cells

Breast Cancer with Bone Metastasis: Molecular Insights and Clinical Management

Postmenopausal Patient With ER+ Early-Stage Breast Cancer: Bone Protection and Shared Decision-Making

Bone Protection During Chemotherapy in Metastatic Lung Cancer

Dosing and Duration of BMAs in an Older Patient With Prostate Cancer

Fast Facts #3: Prostate Cancer and Bone Metastases